Harbour Investments
CRMD icon

Harbour Investments’s CorMedix CRMD Stock Holding History

Harbour Investments’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Hold
1,500
– – ﹤0.01% 3268
2026
Q1 		$10.2K Hold
1,500
– – ﹤0.01% 3253
2025
Q4 		$17.4K Buy
+1,500
New +$16.6K ﹤0.01% 2478
2024
Q1 		– Sell
-50
Closed -$188 – 3234
2023
Q4 		$188 Hold
50
– – ﹤0.01% 3014
2023
Q3 		$185 Buy
+50
New +$199 ﹤0.01% 2891

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Oberweis Asset Management
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Harbour Investments's CRMD Position: Q2 2026 in Review

Harbour Investments held its CorMedix (CRMD) position steady in Q2 2026 at 1,500 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3268.

Harbour Investments first reported a position in CRMD in Q3 2023 and has held it in 5 quarters since. The position peaked at $17.4K in Q4 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Harbour Investments held 1,500 shares of CorMedix worth $11.8K as of Q2 2026.
  • Harbour Investments left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3268 holding.
  • Harbour Investments first reported a position in CorMedix in Q3 2023 and has held it in 5 quarters since.
  • Harbour Investments's CorMedix position peaked at $17.4K in Q4 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.